Analysis of chromosomal imbalances in sporadic and NFI-associated peripheral nerve sheath tumors by comparative genomic hybridization

Genes Chromosomes and Cancer

Volumn 25, Issue 4, 1999, Pages 362-369

  Mechtersheimer, Gunhild ^a   Otaño Joos, Marta ^a   Ohl, Sibylle ^b   Benner, Axel ^b   Lehnert, Thomas ^c   Willeke, Frank ^c   Möller, Peter ^d   Otto, Herwart F ^a   Lichter, Peter ^b   Joos, Stefan ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CHROMOSOME BAND; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA SEQUENCE; GENETIC SCREENING; HUMAN; HUMAN TISSUE; KARYOTYPING; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL;

EID: 0344224273     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199908)25:4<362::AID-GCC8>3.0.CO;2-Q     Document Type: Article

References (43)

1. Andersen LB, Fountain JW, Gutmann DH, Tarlé SA, Glover TW, Dracopoli NC, Housman DE, Collins FS. 1993. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet 3:118-121.
2. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA. 1993. Clonal chromosome aberrations in neurinomas. Genes Chromosomes Cancer 6:206-211.
3. Bentz M, Döhner H, Huck K, Schütz B, Ganser A, Joos S, du Manoir S, Lichter P. 1995. Comparative genomic hybridization in the investigation of myeloid leukemias. Genes Chromosomes Cancer 12:193-200.
4. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D, Sidransky D. 1995. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 11:210-212.
5. Cawthon RM, Weiss R, Xu G, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O'Connell P, White R. 1990. A major segment of the neurofibromatosis type 1 gene: c-DNA sequence, genomic structure, and point mutations. Cell 62:193-201.
6. Couturier J, Delattre O, Kujas M, Philippon J, Peter M, Rouleau G, Aurias A, Thomas G. 1990. Assessment of chromosome 22 anomalies in neurinomas by combined karyotype and RFLP analyses. Cancer Genet Cytogenet 45:55-62.
7. Du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T. 1993. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590-610.
8. El-Rifai W, Sarlomo-Rikala M, Miettinen M, Knuutila S, Andersson LC. 1996. DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors. Cancer Res 56:3230-3233.
9. Enzinger FM, Weiss SW. 1995. Soft Tissue Tumors. St. Louis: CV Mosby.
10. Fleiss J. 1981. Statistical Methods for Rates and Proportions. New York: John Wiley and Sons.
11. Fuller G, Bigner S. 1992. Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res 276:299-306.
12. Glover TW, Stein CK, Legius E, Andersen LB, Brereton A, Johnson S. 1991. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosomes Cancer 3:62-70.
13. Hochberg Y. 1988. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800-802.
14. Jacks T, Shih S, Schmitt EM, Bronson TT, Bernards A, Weinberg RA. 1994. Tumor predisposition in mice heterozygous for a targeted mutation in NF1. Nat Genet 7:353-361.
15. Jhanwar SC, Chen Q, Li FP, Brennan MF, Woodruff JM. 1994. Cytogenetic analysis of soft tissue sarcomas: recurrent chromosome abnormalities in malignant peripheral nerve sheath tumors (MPNST). Cancer Genet Cytogenet 78:138-144.
16. Joos S, Scherthan H, Speicher MR, Schlegel J, Cremer T, Lichter P. 1993. Detection of amplified genomic sequences by reverse chromosome painting using genomic tumor DNA as probe. Hum Genet 90:584-589.
17. Joos S, Bergerheim USR, Pan Y, Matsuyama H, Bentz M, du Manoir S, Lichter P. 1995. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 14:267-276.
18. Joos S, Otaño-Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M, Möller P, Lichter P. 1996. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 87:1571-1578.
19. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D. 1997. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90:809-819.
20. Kalaydjieva L, Lallmayer J, Chandler D, Sovov A, Nikolova A, Angelicheva D, King RHH, Ishpekova B, Honeyman K, Calafell F, Shmarov A, Petrova J, Turnev I, Hristova A, Moskov M, Staneheva S, Petkova I, Bittles AH, Georgieva V, Middleton I, Thomas PK. 1996. Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24. Nat Genet 14:214-217.
21. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
22. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM. 1994. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160.
23. Knuutila S, Björkqvist A-M, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy M, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius V-M, Vidgren V, Zhu Y. 1997. DNA copy number amplifications in human neoplasms. Am J Pathol 152:1107-1123.
24. Krone W, Högemann I. 1986. Cell culture studies on neurofibromatosis (von Recklinghausen) V: monosomy 22 and other chromosomal anomalities in cultures from peripheral neurofibromatosis. Hum Genet 74:453-155.
25. Lastowska M, Cotterill S, Pearson AD, Roberts P, McGuckin A, Lewis I, Bown N. 1997. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients: U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group. Eur J Cancer 33:1627-1623.
26. Legius E, Marchuk DA, Collins FS, Glover TW. 1993. Somatic deletion of neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumor suppressor gene hypothesis. Nat Genet 3:122-126.
27. Li V, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, Friedman E, Samowitz W, Robertson M, Bradley P, McCormick F, White R, Cawthon RM. 1992. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69:275-281.
28. Lothe RA, Slettan A, Saeter G, Brogger A, Borresen AL, Nesland JM. 1995. Alterations at chromosome 17 loci in peripheral nerve sheath tumors. J Neuropathol Exp Neurol 54:65-73.
29. Lothe RA, Karhu R, Mandahl N, Mertens F, Saeter G, Heim S, Borresen-Dale A-L, Kallioniemi O-P. 1996. Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis. Cancer Res 56:4778-4781.
30. McComb EN, McComb RD, DeBoer JM, Neff JR, Bridge JA. 1996. Cytogenetic analysis of a malignant triton tumor and a malignant peripheral nerve sheath tumor and a review of the literature. Cancer Genet Cytogenet 91:8-12.
31. Menon AG, Anderson KM, Riccardi VN, Chung RY, Whaley JM, Yandell DW, Farmer GE, Freiman RN, Lee JK, Li FP, Baker D, Ledbetter DH, Kleider A, Martuza RL, Gusella JF, Seizinger BR. 1990. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 87:5435-5439.
32. Mertens F, Rydholm A, Bauer HFC, Limon J, Nedoszytko B, Szadowska A, Willén H, Heim S, Mitelman F, Mandahl N. 1995. Cytogenetic findings in malignant peripheral nerve sheath tumors. Int J Cancer 61:793-798.
33. National Institutes of Health Consensus Development Conference Statement. 1988. Neurofibromatosis. Neurofibromatosis 1:172-178.
34. Peters G. 1994. Stifled by inhibitions. Nature 371:204-205.
35. Serra E, Puig S, Otero D, Gaona A, Kruyer H, Ars E, Estivill X, Lazaro C. 1997. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 61:512-519.
36. Solinas-Toldo S, Wallrapp C. Müller-Pillasch F, Bentz M, Gress T, Lichter P. 1996. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 56:3803-3807.
37. Stenman G, Kindblom LG, Johansson M, Angervall L. 1991. Clonal chromosome abnormalities and in vitro growth characteristics of classical and cellular schwannomas. Cancer Genet Cytogenet 57:121-131.
38. Suijkerbuijk RF, Olde Weghuis DEM, van den Berg M, Pedeutour F, Forus A, Myklebost O, Glier C, Turc-Carel C, Geurts van Kessel A. 1994. Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well-differentiated liposarcomas. Genes Chromosomes Cancer 9:292-295.
39. Takita J, Yasuhide H, Takashi K, Yamaguchi N, Hanada R, Yamamoto K, Yokota J. 1997. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. Cancer Res 57:907-912.
40. The I, Murthy AE, Hannigan GE, Jacoby LB, Menon AG, Gusella JF, Bernards A. 1993. Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat Genet 3:62-66.
41. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS. 1990. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249:181-186.
42. Weber RG, Boström J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P. 1997. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719-14724.
43. Wunder J, Czitrom A, Kandel R, Andrulis I. 1991. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst 83:194-200.